Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

This study has been completed.
Information provided by (Responsible Party):
Boehringer Ingelheim Identifier:
First received: July 15, 2014
Last updated: NA
Last verified: July 2014
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)